BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36223778)

  • 1. TRANSPLANTATION OF SUBRETINAL STEM CELL-DERIVED RETINAL PIGMENT EPITHELIUM FOR STARGARDT DISEASE: A Phase I Clinical Trial.
    Brant Fernandes RA; Lojudice FH; Zago Ribeiro L; Santos da Cruz NF; Polizelli MU; Cristovam PC; Innocenti F; Morimoto L; Magalhães O; Ferraz Sallum JM; Penha FM; Sogayar MC; Belfort R; Maia M
    Retina; 2023 Feb; 43(2):263-274. PubMed ID: 36223778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term safety and tolerability of subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium in Asian Stargardt disease patients.
    Sung Y; Lee MJ; Choi J; Jung SY; Chong SY; Sung JH; Shim SH; Song WK
    Br J Ophthalmol; 2021 Jun; 105(6):829-837. PubMed ID: 32727729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.
    Humayun MS; Clegg DO; Dayan MS; Kashani AH; Rahhal FM; Avery RL; Salehi-Had H; Chen S; Chan C; Palejwala N; Ingram A; Mitra D; Pennington BO; Hinman C; Faynus MA; Bailey JK; Johnson LV; Lebkowski JS
    Ophthalmology; 2024 Jun; 131(6):682-691. PubMed ID: 38160882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I clinical trial of human embryonic stem cell-derived retinal pigment epithelial cells for early-stage Stargardt macular degeneration: 5-years' follow-up.
    Li SY; Liu Y; Wang L; Wang F; Zhao TT; Li QY; Xu HW; Meng XH; Hao J; Zhou Q; Wang L; Yin ZQ
    Cell Prolif; 2021 Sep; 54(9):e13100. PubMed ID: 34347352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD; Regillo CD; Lam BL; Eliott D; Rosenfeld PJ; Gregori NZ; Hubschman JP; Davis JL; Heilwell G; Spirn M; Maguire J; Gay R; Bateman J; Ostrick RM; Morris D; Vincent M; Anglade E; Del Priore LV; Lanza R
    Lancet; 2015 Feb; 385(9967):509-16. PubMed ID: 25458728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drusenoid pigment epithelial detachment volume is associated with a decrease in best-corrected visual acuity and central retinal thickness: the Norwegian Pigment Epithelial Detachment Study (NORPED) report no. 1.
    Tvenning AO; Krohn J; Forsaa V; Malmin A; Hedels C; Austeng D
    Acta Ophthalmol; 2020 Nov; 98(7):701-708. PubMed ID: 32243712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
    Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
    Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best disease presenting as subretinal pigment epithelium hyperreflectivite lesion on spectral-domain optical coherence tomography: Multimodal imaging features.
    Sayman Muslubas I; Arf S; Hocaoglu M; Giray Ersoz M; Karacorlu M
    Eur J Ophthalmol; 2022 Sep; 32(5):2702-2711. PubMed ID: 34806463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcomes of conventional or high-dose ranibizumab for vascularized pigment epithelial detachment based on lesion subtypes.
    Chan CK; Sarraf D; Abraham P
    Eur J Ophthalmol; 2018 Nov; 28(6):677-683. PubMed ID: 29575941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.
    el Matri L; Chebil A; Kort F; Bouraoui R; Baklouti K; Mghaieth F
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):779-84. PubMed ID: 20169357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MORPHOLOGY SCORE AS A MARKER OF RETINAL FUNCTION IN DRUSENOID PIGMENT EPITHELIAL DETACHMENT.
    Clemens CR; Alten F; Heiduschka P; Eter N
    Retina; 2015 Jul; 35(7):1351-9. PubMed ID: 25658174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
    Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.
    Hoerster R; Muether PS; Sitnilska V; Kirchhof B; Fauser S
    Retina; 2014 Sep; 34(9):1767-73. PubMed ID: 24936942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Innovative Surgical Technique for Subretinal Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigmented Epithelium in Yucatan Mini Pigs: Preliminary Results.
    Brant Fernandes RA; Koss MJ; Falabella P; Stefanini FR; Maia M; Diniz B; Ribeiro R; Hu Y; Hinton D; Clegg DO; Chader G; Humayun MS
    Ophthalmic Surg Lasers Imaging Retina; 2016 Apr; 47(4):342-51. PubMed ID: 27065374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.